EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Upregulation of Immune checkpoint PD-L1 in Colon cancer cell lines and activation of T cells by Leuconostoc mesenteroides

Safaa Altves, Ebru Guclu, Esra Yetisgin, Kivanc Bilecen, Hasibe Vural

World Journal of Microbiology and Biotechnology · 2024-07 · 40 (7)

DOI: 10.1007/s11274-024-04018-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Microbiology and Biotechnology, online erschienen am 17.05.2024. Verfasst von Safaa Altves und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey. safaa.e.t@gmail.com. Hauptthemen laut MEDLINE: B7-H1 Antigen, Colonic Neoplasms, Interferon-gamma, Leuconostoc mesenteroides. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Necmettin Erbakan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Globally colorectal cancer ranks as the third most widespread disease and the third leading cause of cancer-associated mortality. Immunotherapy treatments like PD-L1 blockade have been used to inhibit the PD-L1 legend, which boosts the activity of cytotoxic T lymphocytes. Recently, studies suggest that some probiotics could potentially enhance the effectiveness of immunotherapy treatments for cancer patients. We found that in Caco-2 and HT-29 cells, the live Leuconostoc mesenteroides treatment resulted an increase in the PD-L1 expression and this treatment stimulated interferon-gamma (IFN-γ) production in Jurkat T-cells. Due to the well-established ability of IFN-γ to enhance PD-L1 expression, the combination of IFN-γ and L. mesenteroides was used in colon cancer cell lines and a resulting remarkable increase of over tenfold in PD-L1 expression was obtained. Interestingly, when L. mesenteroides and IFN-γ are present, the blockage of PD-L1 using PD-L1 antibodies not only improved the viability of Jurkat T-cells but also significantly boosted the levels of IFN-γ and IL-2, the T-cells activation marker cytokines. In addition to upregulating PD-L1, L. mesenteroides also activated Toll-like receptors (TLRs) and NOD-like receptors (NODs) pathways, specifically through TLR2 and NOD2, while also exerting a suppressive effect on autophagy in colon cancer cell lines. In conclusion, our findings demonstrate a significant upregulation of PD-L1 expression in colon cancer cells upon co-culturing with L. mesenteroides . Moreover, the presence of PD-L1 antibodies during co-culturing activates Jurkat T cells. The observed enhancement in PD-L1 expression may be attributed to the inhibition of the Autophagy pathway or activation of the hippo pathway. Graphical abstract text The administration of Live Lactobacillus mesenteroides on colon cancer cells leads to the elevation of PD-L1, with a further increase observed in the presence of IFN-γ. Co-cultivation of Live L. mesenteroides with colon cancer cells in conjunction with anti-PD-L1 blockade antibody results in the enhanced viability of T cells. Key Points Co-culturing L. mesenteroides increases PD-L1 gene and protein transaction in colon cancer. L. mesenteroides existing enhances T cells viability and activity. GPCR41/42 is a possible link between L. mesenteroides , YAP-1 and PD-L1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenColonic NeoplasmsInterferon-gammaLeuconostoc mesenteroidesT-LymphocytesHumansCaco-2 CellsCell Line, TumorHT29 CellsInterleukin-2Jurkat CellsLymphocyte ActivationNod2 Signaling Adaptor ProteinProbioticsToll-Like Receptor 2Up-Regulation

Stichwörter der Autor:innen

Leuconostoc mesenteroidesImmunotherapyPD-L1Probiotic

Substanzen

B7-H1 AntigenCD274 protein, humanInterferon-gammaInterleukin-2NOD2 protein, humanNod2 Signaling Adaptor ProteinToll-Like Receptor 2

Autor:innen und Institutionen

  • Department of Medical Biology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey. safaa.e.t@gmail.com.
  • Science and Technology Research and Application Center (BITAM), Necmettin Erbakan University, Konya, Turkey. safaa.e.t@gmail.com.
  • Department of Basic Science and Health, Hemp Research Institute, Yozgat Bozok University, Yozgat, Turkey.
  • Department of Molecular Biology & Genetics, Faculty of Agriculture and Natural Sciences, Konya Food and Agriculture University, Safaa ALTVES, Konya, Turkey.
  • Department of Medical Biology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.

Förderung

  • Necmettin Erbakan University

Zitieren

APA

Altves, S., Guclu, E., Yetisgin, E., Bilecen, K., & Vural, H. (2024). Upregulation of Immune checkpoint PD-L1 in Colon cancer cell lines and activation of T cells by Leuconostoc mesenteroides. World Journal of Microbiology and Biotechnology, 40(7). https://doi.org/10.1007/s11274-024-04018-7

Vancouver

Altves S, Guclu E, Yetisgin E, Bilecen K, Vural H. Upregulation of Immune checkpoint PD-L1 in Colon cancer cell lines and activation of T cells by Leuconostoc mesenteroides. World Journal of Microbiology and Biotechnology. 2024;40(7). doi:10.1007/s11274-024-04018-7

BibTeX
@article{Altves2024,
  author = {Altves, Safaa and Guclu, Ebru and Yetisgin, Esra and Bilecen, Kivanc and Vural, Hasibe},
  title = {Upregulation of Immune checkpoint PD-L1 in Colon cancer cell lines and activation of T cells by Leuconostoc mesenteroides},
  journal = {World Journal of Microbiology and Biotechnology},
  year = {2024},
  volume = {40},
  number = {7},
  doi = {10.1007/s11274-024-04018-7}
}
Kostenlos starten →